Neuberger High Yield Strategies Fund Inc. NHS
The SEC does not publish structured financial data (XBRL) for Neuberger High Yield Strategies Fund Inc., so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| NPORT-P | Filing | Sep 28, 2026 | Jul 31, 2026 |
| N-PX | Filing | Aug 20, 2026 | Jun 30, 2026 |
| DEF 14A | Proxy statement | Aug 6, 2026 | Sep 16, 2026 |
| 40-17G | Fidelity bond filed pursuant to rule 17g1(g)(1) of the investment company act of | Aug 5, 2026 | — |
| N-CSRS | Certified semi-annual shareholder report of registered management investment com | Jun 26, 2026 | Apr 30, 2026 |
| NPORT-P | Filing | Jun 26, 2026 | Apr 30, 2026 |
| NPORT-P | Filing | Mar 24, 2026 | Jan 31, 2026 |
| POS EX | Post-effective amendment filed solely to add exhibits to a registration statemen | Mar 24, 2026 | — |
| 424B2 | Prospectus | Mar 23, 2026 | — |
| 497AD | March 2026 nhs rights offering press release | Mar 13, 2026 | — |
Company profile
- Listed as
- NHS (NYSE)
- Fiscal year ends
- October 31
- Headquarters
- New York, NY
- SEC CIK
- 1487610
- Former names
- Neuberger Berman High Yield Strategies Fund Inc. (until Dec 18, 2025)
Source: SEC EDGAR filings. This is company-reported data, not investment advice.